Education
About Us
Working with TipRanks
Follow Us
Biosergen AB (SE:BIOSGN)
:BIOSGN
BIOSGN Stock Chart & Stats
kr42.60
<kr0.01(1.20%)
At close: 4:00 PM EST
kr42.60
<kr0.01(1.20%)
Day’s Range― - ―
52-Week Rangekr28.10 - kr67.80
Previous CloseN/A
Volume13.64K
Average Volume (3M)126.26K
Market Cap
kr93.93M
Enterprise Valuekr98.93M
Total Cash (Recent Filing)kr33.27M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-0.49
Next Earnings
Mar 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.18
Shares Outstanding2,348,232
10 Day Avg. Volume207,862
30 Day Avg. Volume126,261
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)2.64
Price to Sales (P/S)0.00
P/FCF Ratio-7.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Biosergen AB News
BIOSGN FAQ
What was Biosergen AB’s price range in the past 12 months?
Biosergen AB lowest stock price was kr28.10 and its highest was kr67.80 in the past 12 months.
What is Biosergen AB’s market cap?
Biosergen AB’s market cap is kr93.93M.
When is Biosergen AB’s upcoming earnings report date?
Biosergen AB’s upcoming earnings report date is Mar 27, 2026 which is in 77 days.
How were Biosergen AB’s earnings last quarter?
Biosergen AB released its earnings results on Nov 19, 2025. The company reported -kr5.182 earnings per share for the quarter, missing the consensus estimate of N/A by -kr5.182.
Is Biosergen AB overvalued?
According to Wall Street analysts Biosergen AB’s price is currently Overvalued.
Does Biosergen AB pay dividends?
Biosergen AB does not currently pay dividends.
What is Biosergen AB’s EPS estimate?
Biosergen AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biosergen AB have?
Biosergen AB has 2,348,232 shares outstanding.
What happened to Biosergen AB’s price movement after its last earnings report?
Biosergen AB reported an EPS of -kr5.182 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.263%.
Which hedge fund is a major shareholder of Biosergen AB?
Currently, no hedge funds are holding shares in SE:BIOSGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Biosergen AB
Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.
Technical Analysis
Alzinova AB
―
Nanologica AB
―
Lipigon Pharmaceuticals AB
―
NextCell Pharma AB
―
Spago Nanomedical AB
―